Abstract |
A hypoxic microenvironment is a hallmark in different types of tumors; this phenomenon participates in a metabolic alteration that confers resistance to treatments. Because of this, it was proposed that a combination of 2-methoxyestradiol (2-ME) and sodium dichloroacetate (DCA) could reduce this alteration, preventing proliferation through the reactivation of aerobic metabolism in lung adenocarcinoma cell line (A549). A549 cells were cultured in a hypoxic chamber at 1% O2 for 72 hours to determine the effect of this combination on growth, migration, and expression of hypoxia-inducible factors (HIFs) by immunofluorescence. The effect in the metabolism was evaluated by the determination of glucose/ glutamine consumption and the lactate/ glutamate production. The treatment of 2-ME (10 μM) in combination with DCA (40 mM) under hypoxic conditions showed an inhibitory effect on growth and migration. Notably, this reduction could be attributed to 2-ME, while DCA had a predominant effect on metabolic activity. Moreover, this combination decreases the signaling of HIF-3α and partially HIF-1α but not HIF-2α. The results of this study highlight the antitumor activity of the combination of 2-ME 10 μl/DCA 40 mM, even in hypoxic conditions.
|
Authors | Yair Romero, Manuel Castillejos-López, Susana Romero-García, Alfonso Salgado Aguayo, Iliana Herrera, Misael O Garcia-Martin, Luz Maria Torres-Espíndola, Maria Cristina Negrete-García, Angel Camarena Olvera, Juan Carlos Huerta-Cruz, Rafael Velazquez Cruz, José Cisneros, Edgar Flores Soto, Héctor Solís-Chagoyán, Criselda Mendoza-Milla, Carlos Cabello-Gutiérrez, Víctor Ruiz, Arnoldo Aquino-Gálvez |
Journal | Oxidative medicine and cellular longevity
(Oxid Med Cell Longev)
Vol. 2020
Pg. 3176375
( 2020)
ISSN: 1942-0994 [Electronic] United States |
PMID | 33149807
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Yair Romero et al. |
Chemical References |
- Antineoplastic Agents
- Apoptosis Regulatory Proteins
- Basic Helix-Loop-Helix Transcription Factors
- HIF3A protein, human
- Hypoxia-Inducible Factor 1, alpha Subunit
- Repressor Proteins
- Glutamine
- endothelial PAS domain-containing protein 1
- Lactic Acid
- Glutamic Acid
- 2-Methoxyestradiol
- Dichloroacetic Acid
- Glucose
|
Topics |
- 2-Methoxyestradiol
(pharmacology, therapeutic use)
- A549 Cells
- Antineoplastic Agents
(pharmacology)
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology, therapeutic use)
- Apoptosis Regulatory Proteins
(metabolism)
- Basic Helix-Loop-Helix Transcription Factors
(metabolism)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, pathology)
- Cell Movement
(drug effects)
- Cell Proliferation
(drug effects)
- Dichloroacetic Acid
(pharmacology, therapeutic use)
- Glucose
(metabolism)
- Glutamic Acid
(metabolism)
- Glutamine
(metabolism)
- Glycolysis
(drug effects)
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
(metabolism)
- Lactic Acid
(metabolism)
- Lung Neoplasms
(drug therapy, pathology)
- Repressor Proteins
(metabolism)
- Signal Transduction
(drug effects)
- Tumor Hypoxia
(drug effects)
- Tumor Microenvironment
(drug effects)
- Wound Healing
(drug effects)
|